Clarus Therapeutics Holdings's ROA from the second quarter of 2022 to the second quarter of 2021 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Clarus Therapeutics Holdings's ROA in the second quarter of 2022?
Clarus Therapeutics Holdings Inc. recorded a cumulative net loss of $-35 million during 12 months ending in the second quarter of 2022, resulting in a negative return on assets (ROA) of -77.13%.

However, within the Healthcare sector 959 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2022 from 5276 to 5278.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2022) II. Quarter	(Mar 31 2022) I. Quarter	(Dec 31 2021) IV. Quarter	(Sep 30 2021) III. Quarter	(Jun 30 2021) II. Quarter
Y / Y Total Assets Change	-16.11 %	2133.62 %	69.82 %	-	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-35	-43	-43	-36	-28
Return On Assets (TTM)	-77.13 %	-88.82 %	-109.99 %	-104.97 %	-123.24 %
CRXT's Total Ranking	# 5278	# 5276	# 5579	#	#
Total Assets (TTM) in million	49	37	52	45	58
Seq. Total Assets Change	34 %	-29.37 %	14.09 %	-22.31 %	3467.97 %
Seq. Net Income Change	-	-	-	-	-

CRXT's 5 Years Annual ROA >> Back to CRXT Management Effectiveness >> Compare CRXT ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 152
Sector	# 960
Overall	# 5159

Return On Assets Statistics
High	Average	Low
-77.13 %	-81.96 %	-88.52 %
(Jun 30 2022)		(Mar 31 2022)

Financial Statements
Clarus Therapeutics Holdings's Assets	$ 49 million	CRXT's Balance sheet
Clarus Therapeutics Holdings's Income	$ -11 million	Quarterly CRXT's Income Statement
CRXT's Income by Division		See CRXT's Income by Division

Annual Return On Assets	(Dec 31 2021) FY 2021	(Dec 31 2020) FY 2020	FY	FY	FY
Y / Y Total Assets Change	93.31 %	-	-	-	-
Total Assets in million	52	27	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-40	4	0	0	0
Annual Return On Assets	-77.75 %	16.24 %	-	-	-

CRXT's 5 Years Annual ROA >> Back to CRXT Management Effectiveness >> Compare CRXT ROA to its Competitors

More Return On Assets Ratios
CRXT's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CRXT's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CRXT's Competitors
Subscribers only: Roa for Clarus Therapeutics Holdings's Suppliers
Subscribers only: Return On Assets for CRXT's Customers

You may also want to know
CRXT's Roi	CRXT's Inventory Turnover Ratio	CRXT's Growth Rates	CRXT's Dividend Comparisons
	CRXT's Profitability Ratios	CRXT's Asset Turnover Ratio	CRXT's Dividend Growth
CRXT's Roe	CRXT's Valuation Ratios	CRXT's Financial Strength Ratios	CRXT's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2022, within Healthcare Sector

ROA

Date modified: 2026-09-26T07:40:27+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.